Cipla is a global pharmaceutical firm that champions its commitment to patients, regulators, customers, employees, investors, and the community. Cipla’s connections make it a reliable partner for global health organizations and stakeholders.
The company continually invests in developing new drug delivery systems, enhancing drug formulation infrastructure, and strengthening technology platforms. Cipla evolves to meet changing pharmaceutical needs and patient requirements, aiming for best-in-class products and therapies.
Cipla built its reputation on a solid foundation of care. Their core mission, “Caring For Life,” guides everything they do. They demonstrated their mission to the world in 2001 when Cipla introduced its triple anti-retroviral therapy for HIV/AIDS in Africa at under a dollar a day, increasing accessibility and affordability.
Now, with a presence in over 80 countries, they offer more than 1,500 products across various therapeutic categories and dosage forms. They are committed to making healthcare more affordable globally by expanding in markets such as India, South Africa, and the U.S., as well as other emerging economies.
